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Abstract 
Background: Infections with multi-drug resistant (MDR) Gram-negative bacteria including Pseudomonas aeruginosa 
(PA) have become a serious threat particularly in hospitalized patients with immunopathological co-morbidities. 
The well-balanced interplay between immune cells, pattern recognition receptors such as Toll-like receptor (TLR)-4 
sensing lipopolysaccharide from Gram-negative bacteria including PA, and evolving pathways is crucial to prevent 
the host from invading (opportunistic) pathogens. Information regarding the molecular mechanisms underlying the 
interactions between intestinal carriage of MDR PA and host immunity during chronic large intestinal inflammation is 
scarce, however.
Methods and results: We therefore perorally challenged conventionally colonized TLR4-deficient  IL10−/− mice and 
 IL10−/− counterparts displaying comparably severe chronic colitis with a clinical MDR PA strain. PA could more suf-
ficiently establish in the intestinal tract of TLR4-deficient  IL10−/− mice until day 14 postinfection (p.i.), whereas within 
48 h the majority of  IL10−/− mice had already expelled the opportunistic pathogen from their guts. Intestinal coloni-
zation properties of PA in TLR4-deficient  IL10−/− mice were associated with distinct genotype-dependent differences 
in gut microbiota compositions before challenge given that TLR4-deficient  IL10−/− mice harbored more fecal entero-
bacteria and enterococci, but lower Clostridium/Eubacterium burdens. At day 14 p.i., PA-induced increases in colonic 
immune cells such as macrophages, monocytes and T-lymphocytes could be observed in TLR4-deficient  IL10−/− 
mice, but not  IL10−/− counterparts, that were accompanied by a more distinct secretion of IFN-γ in the colon and 
TNF in the mesenteric lymph nodes (MLN) of the former as compared to the latter. Conversely, splenic TNF levels were 
lower in TLR4-deficient  IL10−/− mice as compared to  IL10−/− controls at day 14 p.i. Interestingly, more pronounced 
apoptotic responses could be assessed in colonic epithelia of PA-challenged  IL10−/− mice only. This was paralleled by 
enhanced pro-inflammatory cytokine secretion not only in the intestines, but also in extra-intestinal compartments 
of  IL10−/− mice as indicated by increased concentrations of nitric oxide in the colon, IFN-γ in the MLN and IL-12p70 in 
the spleen at day 14 p.i.
Conclusions: Under chronic intestinal inflammatory conditions including  IL10−/− colitis MDR PA-association results 
in well-orchestrated TLR4-dependent immune responses both in intestinal and extra-intestinal compartments. Fur-
ther studies should unravel the underlying molecular mechanisms in more detail.
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Background
Pseudomonas aeruginosa (PA) are strictly aerobic Gram-
negative bacteria that can be ubiquitously found, par-
ticularly in moist environments [1]. A polar flagellum 
and type 4 pili enable bacterial motility and adherence 
to surfaces, but can also initiate inflammatory responses. 
Alginate secretion and biofilm formation, quorum sens-
ing, proteases and an elaborated type 3 secretion system 
further contribute to a diverse arsenal of virulence factors 
facilitating immune escape and establishment in the host 
ecosystem [2, 3]. The well-balanced interplay between 
immune cells, pattern recognition receptors such as Toll-
like receptors (TLRs) and evolving pathways is crucial to 
prevent the host from invading (opportunistic) patho-
gens. In this context TLR4 senses PA lipopolysaccharide 
(LPS), which leads to activation of the NFκB signaling 
pathway and subsequent induction of pro-inflammatory 
cytokine and chemokine secretion with potentially fatal 
outcome [4, 5]. PA is regarded as opportunistic patho-
gen and constitutes one of the most prominent causes 
of acute nosocomial infections, preferably affecting 
immune-compromised individuals with severe co-mor-
bidities and patients admitted to the intensive care unit 
(ICU) [6, 7]. PA-related infections include ventilator-
associated pneumonia, infections of surgical sites, burn 
wounds, and of the urinary tract, associated with mortal-
ity rates of > 30% depending both on the immune status 
of the host and the antimicrobial resistance of the bac-
terial strain [6]. PA is further known to drive chronic 
respiratory infections in patients suffering from cystic 
fibrosis, bronchiectasis or chronic obstructive pulmonary 
disease [7–9]. The alarming scenario of globally emerging 
infections with strains that are resistant to several anti-
microbial classes due to β-lactamases, carbapenemases 
and 16S rRNA methylases [7, 9, 10] has prompted the 
World Health Organization (WHO) to rate multi-drug 
resistant (MDR) Gram-negative species including PA as 
serious threats for human health [11]. Whereas in the 
hospital setting respiratory equipment, water bottles, and 
sinks constitute typical environmental reservoirs [12], 
the human gastrointestinal tract might be considered as 
internal source for PA infection [13, 14]. Even though not 
considered as being part of the human commensal intes-
tinal microbiota, intestinal PA colonization is a prereq-
uisite of infection later on, given that rectally colonized 
individuals harbored a 15 times higher risk for develop-
ment of a PA infection when admitted to an ICU [15]. 
Of note, intestinal PA colonization rates of patients have 
been shown to increase during hospital stay presumably 
due to exposure to contaminated surfaces on wards or 
colonized patients via cross-contamination [13]. Particu-
larly antibiotic treatment facilitated the establishment 
of PA in the patients’ gastrointestinal ecosystem, given 
that antimicrobials also affected the complex intestinal 
microbiota composition that usually prevents the host 
from invading (opportunistic) pathogens [7, 16]. Recent 
surveys revealed that intestinal PA detection rates were 
higher in patients with intestinal inflammatory morbidi-
ties including irritable bowel syndrome [17] or inflamma-
tory bowel disease (IBD) such as ulcerative colitis [18]. 
Whereas the pathogenic potential of PA is well known 
given its diverse arsenal of virulence factors, our knowl-
edge regarding the interplay of PA, commensal intestinal 
microbiota and host immunity, particularly under con-
ditions of intestinal inflammation, is scarce, however. 
This prompted us to study gastrointestinal colonization 
properties and potential TLR4 dependent intestinal as 
well as extra-intestinal immune responses upon MDR PA 
challenge under chronic intestinal inflammatory condi-
tions applying the chronic  IL10−/− colitis mouse model. 
Conventionally colonized but not germfree or second-
ary abiotic  IL10−/− mice develop chronic large intestinal 
inflammation due to antigenic stimuli derived from their 
commensal gut microbiota with progressive aging and 
are considered a valuable mouse model for human intes-
tinal inflammation such as IBD affection the colon [19].
Methods
Ethical statement
All animal experiments were conducted according to the 
European Guidelines for animal welfare (2010/63/EU) 
with approval of the commission for animal experiments 
headed by the “Landesamt für Gesundheit und Soziales” 
(LaGeSo, Berlin; Registration Numbers G0097/12 and 
G0039/15). Animal welfare was monitored twice daily by 
assessment of clinical conditions of mice.
Mice and P. aeruginosa infection
Female and male  IL10−/− mice as well as TLR4 deficient 
 IL10−/− mice  (TLR4−/− × IL10−/−), all in C57BL/10ScSn 
background, were reared and maintained within the 
same specific pathogen free (SPF) unit of the Forschun-
gseinrichtungen für Experimentelle Medizin (FEM, 
Charité-University Medicine Berlin). Sex matched, 
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between 11 and 14  months old mice of either genotype 
were perorally challenged with  109 colony forming units 
(CFU) of a MDR P. aeruginosa strain by gavage in a total 
volume of 0.3 mL phosphate buffered saline (PBS; Ginco, 
life technologies, UK) as reported earlier [20]. The P. 
aeruginosa isolate was cultured from respiratory mate-
rial of a patient with nosocomial pneumonia and kindly 
provided by Prof. Dr. Bastian Opitz (Charité-University 
Medicine, Berlin, Germany). Of note, the bacterial strain 
was tested resistant against piperacillin/tazobactam, cef-
tazidime, cefepim  ±  cefoxitin, imipenem, ciprofloxacin, 
gentamycin, tobramycin, amikacin, trimethoprim/sul-
famethoxazole and aztreonam (according to EUCAST 
interpretation guidelines) and displayed antimicrobial 
sensitivity to fosfomycin and colistin only [20].
Cultural analysis of P. aeruginosa
For quantitative assessment of P. aeruginosa coloniza-
tion properties, fecal and luminal samples derived from 
distinct parts of the gastrointestinal tract such as stom-
ach, duodenum, ileum and colon were homogenized in 
sterile PBS. Serial dilutions were streaked onto Columbia 
agar supplemented with 5% sheep blood and Cetrimid 
agar (both Oxoid, Germany) and incubated in an aerobic 
atmosphere at 37 °C for at least 48 h as described previ-
ously [20].
Clinical conditions
To assess clinical signs upon PA challenge on a daily 
basis, a standardized cumulative clinical score (maxi-
mum 12 points), addressing the occurrence of blood in 
feces (0: no blood; 2: microscopic detection of blood by 
the Guajac method using Haemoccult, Beckman Coulter/
PCD, Germany; 4: macroscopic blood visible), diarrhea 
(0: formed feces; 2: pasty feces; 4: liquid feces), and the 
clinical aspect (0: normal; 2: ruffled fur, less locomotion; 
4: isolation, severely compromised locomotion, pre-final 
condition) was used as described earlier [21, 22].
Sampling procedures and histopathology
Mice were sacrificed 14  days postinfection (p.i.) by iso-
flurane treatment (Abbott, Germany). Cardiac blood and 
tissue samples from spleen, liver, kidney, lung, mesenteric 
lymph nodes (MLN), ileum and colon were removed 
under sterile conditions. Intestinal samples were col-
lected from each mouse in parallel for microbiological, 
immunohistochemical and histopathological analyses. 
Histopathological changes were determined in samples 
derived from the colon that were immediately fixed in 
5% formalin and embedded in paraffin. Sections  (5 μm) 
were stained with hematoxylin and eosin (H&E), exam-
ined by light microscopy (magnification 100× and 400×) 
and histopathological changes quantitatively assessed 
applying an established histopathological scoring system 
(maximum 4 points) as described previously [23].
Immunohistochemistry
Colonic paraffin sections  (5 μm) were subjected to 
in  situ immunohistochemical analysis as described ear-
lier [22, 24]. In brief, primary antibodies against cleaved 
caspase-3 (Asp175, Cell Signaling, Beverly, MA, USA, 
1:200), Ki67 (TEC3, Dako, Glostrup, Denmark, 1:100), 
F4/80 (# 14-4801, clone BM8, eBioscience, 1:50), CD3 
(#N1580, Dako, 1:10), FOXP3 (FJK-16 s, eBioscience, San 
Diego, CA, USA, 1:100) and B220 (eBioscience, 1:200) 
were used to detect apoptotic cells, proliferating cells, 
macrophages/monocytes, T lymphocytes, regulatory T 
cells (Treg) and B lymphocytes, respectively. The average 
numbers of positively stained cells within at least six high 
power fields (HPF, 0.287 mm2; 400× magnification) were 
determined by an independent blinded investigator.
Cultural survey of intestinal microbiota
For comprehensive quantitative survey of the  intestinal 
microbiota composition, colonic luminal contents were 
homogenized in sterile PBS and analyzed in serial dilu-
tions on respective solid media as described earlier [25–
27]. Bacteria were grown at 37 °C for at least 2 and 3 days 
under aerobic, microaerobic and anaerobic conditions. 
Following subcultivation of bacteria with distinct colony 
morphotypes, respective species were identified by bio-
chemical analysis and 16S rRNA sequencing [25–27]. 
The detection limit of viable bacteria was approximately 
100 CFU/g.
Cytokine detection
Ex vivo biopsies (approximately 1  cm2) derived from 
colon (cut longitudinally and washed in PBS), MLN and 
spleen were placed in 24-flat-bottom well culture plates 
(Falcon, Germany) containing 500 mL serum-free RPMI 
1640 medium (Gibco, life technologies) supplemented 
with penicillin (100  U/mL, Biochrom, Germany) and 
streptomycin (100 µg/mL; Biochrom). After 18 h at 37 °C, 
culture supernatants were tested for IFN-γ, TNF and 
IL-12p70 by the Mouse Inflammation Cytometric Bead 
Assay (CBA; BD Bioscience) on a BD FACSCanto II flow 
cytometer (BD Bioscience). Nitric oxide (NO) was deter-
mined by the Griess reaction as described earlier [25]. 
Obtained cytokine levels were normalized to mg protein.
Statistical analysis
Mean values, medians, and levels of significance as 
assessed by Mann–Whitney-U Test and Wilcoxon Test 
were determined using GraphPad Prism Software v5 (La 
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Jolla, CA, USA). Two-sided probability (p) values ≤ 0.05 
were considered significant. Experiments were repeated 
twice.
Results
Intestinal colonization properties of multi‑drug resistant P. 
aeruginosa following peroral association of TLR4 deficient 
 IL10−/− mice
In order to address the impact of TLR4 in MDR PA 
colonization and subsequent intestinal as well as extra-
intestinal immune responses in murine  IL10−/− colitis, 
we perorally challenged 11–14  months old convention-
ally colonized TLR4 deficient  IL10−/− mice and  IL10−/− 
counterparts with  109 CFU of a clinical MDR PA isolate 
by gavage. Whereas 24 h later all  IL10−/− mice harbored 
the bacterial strain in their intestines with median loads 
of approximately  106 CFU/g (p < 0.001 versus d0; Fig. 1a), 
fecal PA loads declined thereafter (p < 0.001 versus day 1 
p.i.; Fig. 1a). Of note, as early as 48 h p.i., more than 50% 
of mice had already expelled the opportunistic pathogen 
from their intestinal tract, whereas later on, PA could be 
isolated from fecal samples in single cases only (Fig. 1a). 
In TLR4 deficient  IL10−/− mice, however, fecal PA loads 
were significantly higher as compared to  IL10−/− coun-
terparts from day 3 p.i. until the end of the observation 
period (p < 0.05–0.001; Fig. 1b). In addition, only 23.8% 
of  IL10−/− mice harbored PA in their intestines at day 14 
p.i., whereas 63.6% of fecal samples derived from TLR4 
deficient  IL10−/− mice were PA-positive (Fig. 1). At nec-
ropsy, detection rates as well as bacterial burdens were 
higher in stomach, ileum and colon of TLR4 deficient 
 IL10−/− mice as compared to  IL10−/− controls (p < 0.01; 
Fig.  2). Hence, MDR PA could more sufficiently estab-
lish within the gastrointestinal tract of TLR4 deficient 
 IL10−/− mice.
Intestinal microbiota composition before peroral 
association of TLR4 deficient  IL10−/− mice with multi‑drug 
resistant P. aeruginosa
Given that the intestinal microbiota composition consti-
tutes the physiological colonization resistance prevent-
ing the host from (opportunistic) pathogenic infection 
[27], we next performed a comprehensive survey of the 
commensal intestinal microbiota composition in mice 
of either genotype by cultural analyses of fecal samples 
that had been taken immediately before PA challenge. 
Fig. 1 Intestinal colonization properties of multi-drug resistant P. aeruginosa following peroral association of  IL10−/− mice lacking TLR4. Conven-
tionally colonized a IL10 deficient  (IL10−/−; closed circles) and b TLR4 deficient  IL10−/− mice  (TLR4−/− × IL10−/−; closed triangles) were perorally 
challenged with a clinical multi-drug resistant P. aeruginosa strain at day (d) 0. Intestinal colonization densities were determined in fecal samples 
until d14 postinfection by culture and expressed as colony forming units per gram (CFU/g). Numbers of mice harboring P. aeruginosa out of the 
total number of analyzed mice (in parentheses), medians (black bars) and significance levels (p values) determined by Mann–Whitney U test and 
Wilcoxon Test are indicated. Asterisks illustrate significant differences between genotypes at defined time points (*p < 0.05; **p < 0.01; ***p < 0.001); 
#p < 0.001 (d1 versus all other time points); §p < 0.001 (d0 versus all other time points). p values in numbers indicate differences between mice of 
identical genotype at distinct time points as shown by the horizontal bar underneath. Data shown were pooled from at least three independent 
experiments
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Interestingly, TLR4 deficient  IL10−/− mice harbored 
up to two orders of magnitude higher numbers of com-
mensal enterobacteria and enterococci in their intestinal 
tract at day 0 (p < 0.001 and p < 0.01, respectively; Fig. 3), 
whereas fecal obligate anaerobic Clostridium/Eubacte-
rium spp. were lower as compared to  IL10−/− controls 
(p < 0.01, Fig. 3). Hence, TLR4-dependent differences in 
intestinal colonization properties of MDR PA were asso-
ciated with genotype-dependent differences in intestinal 
microbiota compositions of  IL10−/− mice before peroral 
PA challenge and subsequently facilitated PA coloniza-
tion in TLR4 deficient  IL10−/− mice.
Macroscopic and microscopic sequelae in TLR4 deficient 
 IL10−/− mice following peroral association with multi‑drug 
resistant P. aeruginosa
We next assessed potential TLR4 dependent macroscopic 
and microscopic sequelae upon MDR PA colonization of 
 IL10−/− mice. Whereas in the basal state TLR4 deficient 
 IL10−/− mice displayed slightly higher clinical scores 
indicative for ruffled fur and/or microscopic abundance 
of fecal blood, but in single cases only (p < 0.05; Fig. 4a), 
clinical conditions were comparable at day 14 following 
PA colonization of mice of either genotype. Whereas 
neither in PA colonized nor in naive  IL10−/− mice fecal 
blood could be detected, this was the case in 33.3 and 
18.2% of naïve and PA associated TLR4 deficient  IL10−/− 
mice, respectively (Fig.  4b). In line with their macro-
scopic aspects, mice of either genotype displayed chronic 
colitis of moderate but comparable severity (Fig. 5a) with 
mucosal and submucosal inflammatory infiltrates and 
dysplastic crypts that could be observed both before 
and 14 days after PA challenge (Additional file 1: Figure 
S1). Given that apoptosis is a suitable marker for grad-
ing of intestinal inflammation [28], we next quantitatively 
assessed colonic apoptosis applying in situ immunohisto-
chemistry. At day 14 p.i., increased numbers of apoptotic 
cells could be observed in the large intestinal epithelia 
of  IL10−/− (p  <  0.05), but not TLR4 deficient  IL10−/− 
mice (Fig.  5b). Of note, numbers of colonic Ki67+ cells 
indicative for cell proliferation and regeneration thereby 
counteracting potential cell damage were unchanged 
upon PA association of mice of either genotype (n.s.; 
Fig. 5c). Hence, apoptotic cell responses upon MDR PA 
colonization were more pronounced in large intestines of 
 IL10−/− mice.
Fig. 2 Multi-drug resistant P. aeruginosa loads in the gastrointestinal 
tract following peroral association of  IL10−/− mice lacking TLR4. 
Conventionally colonized IL10 deficient (WT  IL10−/−; closed circles) 
and TLR4 deficient  IL10−/− mice  (TLR4−/− × IL10−/−; closed triangles) 
were perorally challenged with a clinical multi-drug resistant P. 
aeruginosa strain at day (d) 0. At necropsy (i.e. d14 postinfection), 
P. aeruginosa loads were quantitatively assessed in gastrointestinal 
luminal samples derived from stomach, duodenum, ileum und colon 
by culture and expressed as colony forming units per gram (CFU/g). 
Numbers of mice harboring P. aeruginosa out of the total number of 
analyzed mice (in parentheses), medians (black bars) and significance 
levels (p values) determined by Mann–Whitney U test are indicated. 
Data were pooled from at least three independent experiments
Fig. 3 Intestinal microbiota composition before peroral association 
of  IL10−/− mice lacking TLR4 with multi-drug resistant P. aeruginosa. 
Immediately before peroral challenge with a clinical multi-drug resist-
ant P. aeruginosa strain at day (d) 0, a comprehensive survey of the 
intestinal microbiota composition was performed on fecal samples 
derived from conventionally colonized IL10 deficient (WT  IL10−/−; 
open circles) and TLR4 deficient  IL10−/− mice  (TLR4−/− × IL10−/−; 
open triangles), and the following intestinal commensal bacteria 
were assessed by culture (expressed as colony forming units per 
gram, CFU/g): Enterobacteria (EB), enterococci (EC), lactic acid 
bacteria (LAB), Bacteroides/Prevotella spp. (B/P), Clostridium/Eubac-
terium spp. (C/E) and total bacterial loads (TL). Numbers of mice 
harboring the respective commensal intestinal bacteria out of the 
total number of analyzed mice (in parentheses), medians (black bars) 
and significance levels (p values) determined by Mann–Whitney U 
test are indicated. Data were pooled from at least three independent 
experiments
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Fig. 4 Clinical conditions in  IL10−/− mice lacking TLR4 following peroral association with multi-drug resistant P. aeruginosa. Conventionally 
colonized IL10 deficient (WT  IL10−/−; closed circles) and TLR4 deficient  IL10−/− mice  (TLR4−/− × IL10−/−; closed triangles, black bar) were perorally 
challenged with a clinical multi-drug resistant P. aeruginosa (PA) strain at day (d) 0. a Clinical symptoms (applying a standardized clinical scoring 
system) and b fecal blood-positivity rates were surveyed at day 14 p.i. Naive (N) mice served as negative controls (white bar). Numbers of mice 
displaying clinical symptoms including blood-positive feces out of the total numbers of analyzed animals (in parentheses), median (black bars; a), 
blood-positivity rates ± standard deviations (in %; b) and significance levels (p values) determined by the Mann–Whitney U test are indicated. Data 
shown were pooled from three independent experiments
Fig. 5 Histopathological mucosal changes, apoptotic and proliferating epithelial cells in large intestines of  IL10−/− mice lacking TLR4 following 
peroral association with multi-drug resistant P. aeruginosa. Conventionally colonized IL10 deficient (WT  IL10−/−; closed circles) and TLR4 deficient 
 IL10−/− mice  (TLR4−/− × IL10−/−; closed triangles) were perorally challenged with a clinical multi-drug resistant P. aeruginosa (PA) strain at day (d) 0. 
Fourteen days thereafter a histopathological mucosal changes were assessed in hematoxylin and eosin stained colonic paraffin sections applying 
a standardized histopathological scoring system. In addition, the average numbers of colonic epithelial, b apoptotic (positive for caspase 3, Casp3) 
and c proliferating cells (positive for Ki67) were determined from six high power fields (HPF, 400× magnification) per animal in immunohisto-
chemically stained large intestinal paraffin sections. Naive (N) mice served as negative controls (open symbols). Numbers of mice (in parentheses), 
median (black bars) and significance levels (p values) determined by the Mann–Whitney U test are indicated. Data shown were pooled from three 
independent experiments
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Colonic immune cell responses in TLR4 deficient  IL10−/− 
mice following peroral association with multi‑drug 
resistant P. aeruginosa
We next addressed whether PA colonization resulted 
in TLR4 dependent immune cell responses within the 
intestinal tract. We therefore quantitatively determined 
numbers of large intestinal innate (i.e. macrophages 
and monocytes) as well as adaptive (i.e. T lymphocytes, 
Treg and B lymphocytes) immune cell populations by 
in  situ immunohistochemical staining of colonic par-
affin sections with distinct antibodies. At day 14 p.i., 
increased numbers of macrophages and monocytes could 
be observed in the large intestinal mucosa and lamina 
propria of TLR4 deficient  IL10−/− mice (p  <  0.05), but 
not  IL10−/− controls (Fig.  6a), which also held true for 
colonic T lymphocytes (p < 0.05; Fig. 6b). Whereas Treg 
numbers remained unchanged upon PA challenge (n.s.; 
Fig.  6c), B lymphocytes were elevated in large intes-
tines at day 14 p.i., irrespective of the genotype of mice 
(p < 0.05; Fig. 6d). Hence, distinct innate as well as adap-
tive immune responses upon MDR PA colonization were 
more pronounced in large intestines of TLR4 deficient 
 IL10−/− mice.
Intestinal and extra‑intestinal cytokine responses in TLR4 
deficient  IL10−/− mice following peroral association 
with multi‑drug resistant P. aeruginosa
We next assessed whether observed TLR4 dependent dif-
ferences in colonic immune responses were associated 
with genotype dependent intestinal and even extra-intes-
tinal cytokine secretion. More pronounced apoptotic 
responses in colonic epithelia that had been observed 
exclusively following PA challenge of  IL10−/− mice were 
paralleled by enhanced pro-inflammatory cytokine 
secretion not only in the intestinal tract but also in 
extra-intestinal compartments as indicated by increased 
concentrations of NO in the colon (p  <  0.05; Fig.  7a), 
IFN-γ in the MLN (p < 0.05; Fig. 7b) and IL-12p70 in the 
spleen (p < 0.05; Fig. 7c) of  IL10−/− mice at day 14 p.i.
More prominent colonic abundances of macrophages, 
monocytes and T lymphocytes in PA colonized TLR4 
deficient  IL10−/− mice, however, were accompanied 
by more distinct secretion of IFN-γ in colon (p  <  0.01; 
Fig. 7d) and TNF in MLN (p < 0.05; Fig. 7e) of TLR4 defi-
cient  IL10−/− mice as compared to  IL10−/− counterparts, 
whereas conversely, splenic TNF levels were lower in the 
former than the latter at day 14 p.i. (p  <  0.01; Fig.  7f ). 
Hence, distinct TLR4 dependent pro-inflammatory 
immune response scenarios following intestinal coloni-
zation with MDR PA are mirrored by distinct intestinal 
and even extra-intestinal (i.e. splenic) pro-inflammatory 
cytokine responses.
Discussion
It is under current debate whether mere intestinal car-
riage of the opportunistic pathogen PA does have any 
immunopathological impact in health and disease [20, 
29]. In a previous survey, we were able to show that fol-
lowing peroral challenge of clinically uncompromised 
microbiota-depleted mice with an identical clinical iso-
late, MDR PA was not only able to stably colonize the 
intestinal tract at high loads, but also to induce intestinal 
as well as even extra-intestinal (i.e. splenic) pro-inflam-
matory immune responses [29]. Hence, mere intestinal 
carriage of MDR Gram-negative opportunistic pathogens 
such as PA by an antibiotic-pretreated, but otherwise 
asymptomatic individual might result in immunopatho-
logical sequelae that may even be aggravated by other 
comorbidities (and vice versa). This prompted us to 
unravel the interplay of MDR PA with the commensal 
intestinal microbiota and host immunity during chronic 
inflammation of the large intestinal tract here. Following 
peroral challenge, approximately two-thirds of TLR4 defi-
cient  IL10−/−, but only up to 25% of  IL10−/− counterparts 
harbored MDR PA in their intestine 2  weeks following 
peroral challenge. Given that the intestinal microbiota 
composition determines host resistance against invading 
(opportunistic) pathogens [28], we surveyed the intes-
tinal gut microbiota before peroral challenge of mice of 
either genotype. Cultural analyses revealed that naive, 
conventionally colonized TLR4 deficient  IL10−/− mice 
harbored up to two orders of magnitude higher fecal 
enterobacteria as compared to  IL10−/− controls. In our 
previous studies we were able to demonstrate that ele-
vated intestinal loads of enterobacterial commensals such 
as Escherichia coli were able to override physiological 
colonization resistance and facilitated murine infection 
with the enteropathogen Campylobacter jejuni [30–32]. 
One also needs to take into consideration that intestinal 
inflammation per se might facilitate pathogenic coloniza-
tion [20, 25, 32, 33]. Before PA challenge histopathologi-
cal severities of chronic colitis were comparable in either 
mice, however, and were not further aggravated upon PA 
challenge until the end of the study. The TLR4 depend-
ent colonization properties of MDR PA observed here 
are supported by our very recent survey where we could 
show that healthy microbiota-depleted TLR4 deficient 
 IL10−/− mice harbored higher PA burdens in their gas-
trointestinal tract as compared to microbiota-depleted 
 IL10−/− counterparts [34]. The PA induced intestinal 
and splenic pro-inflammatory immune responses do not 
follow a clear-cut pattern when comparing TLR4 defi-
cient  IL10−/− mice and  IL10−/− controls, however. On 
one hand, besides higher intestinal opportunistic patho-
genic loads, only MDR PA colonized TLR4 deficient 
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 IL10−/− mice displayed increased numbers of innate 
as well as of adaptive immune cell populations such as 
macrophages and monocytes as well as of T lympho-
cytes in their large intestinal mucosa and lamina pro-
pria at day 14 p.i. These increases in immune cells were 
accompanied by more pronounced intestinal secretion of 
pro-inflammatory cytokines such as IFN-γ and TNF in 
colon and MLN, respectively. Of note, splenic TNF con-
centrations were lower in TLR4 deficient  IL10−/− mice as 
compared to  IL10−/− counterparts at day 14 p.i., which 
Fig. 6 Colonic immune cell responses in  IL10−/− mice lacking TLR4 following peroral association with multi-drug resistant P. aeruginosa. Conven-
tionally colonized IL10 deficient (WT  IL10−/−; closed circles) and TLR4 deficient  IL10−/− mice  (TLR4−/− × IL10−/−; closed triangles) were perorally 
challenged with a clinical multi-drug resistant P. aeruginosa (PA) strain at day (d) 0. Fourteen days thereafter, the average numbers of colonic a 
macrophages and monocytes (positive for F4/80), b T lymphocytes (positive for CD3), c regulatory T cells (positive for FOXP3), and d B lymphocytes 
(positive for B220) were determined from six high power fields (HPF, 400× magnification) per animal in immunohistochemically stained large 
intestinal paraffin sections. Naive (N) mice served as negative controls (open symbols). Numbers of mice (in parentheses), medians (black bars) and 
significance levels (p values) determined by the Mann–Whitney U test are indicated. Data shown were pooled from three independent experiments
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might be explained by more pronounced recruitment of 
leukocytes to the intestinal tract. One might argue that 
the more distinct immune responses observed in TLR4 
deficient  IL10−/− mice were merely due to better gastro-
intestinal colonization properties of MDR PA as com-
pared to  IL10−/− control mice. One needs to take into 
consideration, however, that an (opportunistic) patho-
gen does not necessarily need to be permanently abun-
dant within the gastrointestinal tract in order to induce 
immunopathological responses [22, 35–37]. It is rather 
the initial hit by the bacterial stimulus tipping the bal-
ance towards pro-inflammatory immune responses dur-
ing (opportunistic) pathogen–host interactions [35]. In 
fact, despite only sporadic colonization,  IL10−/−, but not 
TLR4 deficient  IL10−/− mice, on the other side, displayed 
increased numbers of apoptotic colonic epithelial cells 
that were paralleled by increased secretion of NO and 
IFN-γ in colon and MLN, respectively, whereas elevated 
IL-12p70 levels could be measured in extra-intestinal 
compartments like the spleen. In support, our very 
recent study revealed that TLR4 mediated PA induced 
inflammatory responses in otherwise healthy secondary 
abiotic  IL10−/− mice without colitis [34]. Lipid A consti-
tutes a core moiety of LPS derived from Gram-negative 
bacteria including Pseudomonas and has been shown to 
activate NFκB signaling via TLR4 leading to increased 
pro-inflammatory cytokine expression [38]. In turn, 
innate immune cells are recruited to the infection site 
and further accelerate host immune responses in order 
to combat the invading (opportunistic) pathogen [3]. The 
Fig. 7 Intestinal and splenic cytokine responses in  IL10−/− mice lacking TLR4 following peroral association with multi-drug resistant P. aeruginosa. 
Conventionally colonized IL10 deficient (WT  IL10−/−; closed circles) and TLR4 deficient  IL10−/− mice  (TLR4−/− × IL10−/−; closed triangles) were 
perorally challenged with a clinical multi-drug resistant P. aeruginosa (PA) strain at day (d) 0. Fourteen days thereafter, secretion of distinct pro-
inflammatory mediators were measured in supernatants of ex vivo biopsies derived from colon (a nitric oxide (NO); d IFN-γ), mesenteric lymph 
nodes (MLN; b IFN-γ; e TNF) and spleen (c IL-12p70; e TNF). Naive (N) mice served as negative controls (open symbols). Numbers of mice (in paren-
theses), medians (black bars) and significance levels (p values) determined by the Mann–Whitney U test are indicated. Data shown were pooled 
from three independent experiments
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impact of TLR4 dependent immunopathological sequelae 
of PA infection is even more intriguing for the following 
reasons. Firstly, mice are up to 1000 times more resistant 
to TLR4 ligands such as LPS than humans, and secondly, 
IL10 gene deficiency renders mice more sensitive to LPS 
action [39].
Conclusions
TLR4 dependent signaling of LPS derived from MDR 
PA differentially mediates both intestinal and splenic 
immune responses in murine chronic  IL10−/− colitis. 
Future studies need to further unravel the underlying 
mechanisms of interactions between MDR (opportunis-
tic) pathogens such as PA, the complex intestinal micro-
biota and host immunity.
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